Literature DB >> 3014866

On the power to detect differences between male and female mutation rates for Duchenne muscular dystrophy, using classical segregation analysis and restriction fragment length polymorphisms.

E R Karel, G J te Meerman, L P Ten Kate.   

Abstract

The power to detect departures from the theoretical proportion of new mutants in X-linked lethal disorders has been analyzed for several types of segregation analysis, including methods based on completely linked restriction fragment length polymorphisms. It is shown that all methods require large sample sizes in order to detect even large differences between male and female mutation rates. Ascertainment bias is shown to have a great effect on the outcome of the segregation analysis. All reviewed studies concerning the proportion of new mutants in Duchenne muscular dystrophy, whether they claimed equality or inequality between the male and female mutation rates, give insufficient evidence because of ascertainment bias and a too low power. An ascertainment bias-free method is given, with the advantage that information from many studies can be combined. By doing so, in the long run, even moderate departures from equality in mutation rates (if present) can be detected.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3014866      PMCID: PMC1684852     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  16 in total

1.  Formal genetics of muscular dystrophy.

Authors:  N E MORTON; C S CHUNG
Journal:  Am J Hum Genet       Date:  1959-12       Impact factor: 11.025

2.  An evaluation of some carrier detection techniques in Duchenne muscular dystrophy.

Authors:  R J Lane; P Maskrey; G A Nicholson; P Q Siddiqui; M Nicholson; P Gascoigne; R J Pennington; D Gardner-Medwin; J N Walton
Journal:  J Neurol Sci       Date:  1979-11       Impact factor: 3.181

3.  A probable sex difference in some mutation rates.

Authors:  F Vogel
Journal:  Am J Hum Genet       Date:  1977-05       Impact factor: 11.025

4.  Sample-size calculations in segregation analysis.

Authors:  F L Wong; J I Rotter
Journal:  Am J Hum Genet       Date:  1984-11       Impact factor: 11.025

5.  Complex segregation analysis and computer-assisted genetic risk assessment for Duchenne muscular dystrophy.

Authors:  W R Williams; M W Thompson; N E Morton
Journal:  Am J Med Genet       Date:  1983-02

6.  Duchenne muscular dystrophy: data from family studies.

Authors:  G A Danieli; M L Mostacciuolo; G Pilotto; C Angelini; A Bonfante
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

7.  Estimation of proportion of new mutants among cases of Duchenne muscular dystrophy.

Authors:  A M Davie; A E Emery
Journal:  J Med Genet       Date:  1978-10       Impact factor: 6.318

8.  The genetic status of mothers of isolated cases of Duchenne muscular dystrophy.

Authors:  R J Lane; M Robinow; A D Roses
Journal:  J Med Genet       Date:  1983-02       Impact factor: 6.318

9.  No sex difference in mutations rates of Duchenne muscular dystrophy.

Authors:  N Yasuda; K Kondô
Journal:  J Med Genet       Date:  1980-04       Impact factor: 6.318

10.  Estimation of male to female ratio of mutation rates from carrier-detection tests in X-linked disorders.

Authors:  R M Winter
Journal:  Am J Hum Genet       Date:  1980-07       Impact factor: 11.025

View more
  10 in total

1.  Sex ratio of the mutation frequencies in haemophilia A: coagulation assays and RFLP analysis.

Authors:  A H Bröcker-Vriends; F R Rosendaal; J C van Houwelingen; E Bakker; G J van Ommen; J J van de Kamp; E Briët
Journal:  J Med Genet       Date:  1991-10       Impact factor: 6.318

2.  Germinal mosaicism and risk calculation in X-linked diseases.

Authors:  M Jeanpierre
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

3.  Intragenic deletions in 21 Duchenne muscular dystrophy (DMD)/Becker muscular dystrophy (BMD) families studied with the dystrophin cDNA: location of breakpoints on HindIII and BglII exon-containing fragment maps, meiotic and mitotic origin of the mutations.

Authors:  B T Darras; P Blattner; J F Harper; A J Spiro; S Alter; U Francke
Journal:  Am J Hum Genet       Date:  1988-11       Impact factor: 11.025

4.  On the estimation of the proportion of sporadic cases in Duchenne muscular dystrophy.

Authors:  G A Danieli; G Barbujani
Journal:  Am J Hum Genet       Date:  1988-01       Impact factor: 11.025

5.  Estimation of the male and female mutation rates in Duchenne muscular dystrophy (DMD).

Authors:  B Müller; C Dechant; G Meng; S Liechti-Gallati; R A Doherty; J F Hejtmancik; E Bakker; A P Read; M Jeanpierre; K H Fischbeck
Journal:  Hum Genet       Date:  1992-05       Impact factor: 4.132

6.  Ascertainment bias and power of procedures to estimate differences between male and female mutation rates.

Authors:  G J te Meerman; E R Karel; L P ten Kate
Journal:  Hum Genet       Date:  1987-03       Impact factor: 4.132

7.  Sporadic cases in Duchenne muscular dystrophy. A reappraisal through segregation analysis on 988 sibships.

Authors:  A Russo; G Barbujani; M L Mostacciuolo; F H Herrmann; A W Spiegler; G Galluzzi; G A Danieli
Journal:  Hum Genet       Date:  1987-07       Impact factor: 4.132

8.  Sex ratio of the mutation frequencies in haemophilia A: estimation and meta-analysis.

Authors:  F R Rosendaal; A H Bröcker-Vriends; J C van Houwelingen; C Smit; I Varekamp; H van Dijck; T P Suurmeijer; J P Vandenbroucke; E Briët
Journal:  Hum Genet       Date:  1990-12       Impact factor: 4.132

9.  Parental origin and germline mosaicism of deletions and duplications of the dystrophin gene: a European study.

Authors:  A J van Essen; S Abbs; M Baiget; E Bakker; C Boileau; C van Broeckhoven; K Bushby; A Clarke; M Claustres; A E Covone
Journal:  Hum Genet       Date:  1992-01       Impact factor: 4.132

10.  Birth and population prevalence of Duchenne muscular dystrophy in The Netherlands.

Authors:  A J van Essen; H F Busch; G J te Meerman; L P ten Kate
Journal:  Hum Genet       Date:  1992-01       Impact factor: 4.132

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.